iclusig 15 mg
50,000 Per 30
Ponatinib is an oral drug developed by ariad pharmaceuticals for the treatment of chronic myeloid leukemia and philadelphia chromosome–positive acute lymphoblastic leukemia. It is a multi-targeted tyrosine-kinase inhibitor
0.0
View Profile
Post Free Ad
